Organogenesis

metrics 2024

Unveiling the Complexities of Organogenesis.

Introduction

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

Metrics 2024

SCIMAGO Journal Rank0.46
Journal Impact Factor1.60
Journal Impact Factor (5 years)2.50
H-Index61
Journal IF Without Self1.60
Eigen Factor0.00
Normal Eigen Factor0.04
Influence0.51
Immediacy Index0.80
Cited Half Life11.20
Citing Half Life5.80
JCI0.42
Total Documents388
WOS Total Citations1113
SCIMAGO Total Citations2841
SCIMAGO SELF Citations37
Scopus Journal Rank0.46
Cites / Document (2 Years)2.05
Cites / Document (3 Years)2.43
Cites / Document (4 Years)2.29

Metrics History

Rank 2024

Scopus

Embryology in Medicine
Rank #7/21
Percentile 66.67
Quartile Q2
Transplantation in Medicine
Rank #19/54
Percentile 64.81
Quartile Q2
Biomedical Engineering in Engineering
Rank #170/303
Percentile 43.89
Quartile Q3
Developmental Biology in Biochemistry, Genetics and Molecular Biology
Rank #50/82
Percentile 39.02
Quartile Q3

IF (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 268/313
Percentile 14.50
Quartile Q4
DEVELOPMENTAL BIOLOGY
Rank 30/39
Percentile 24.40
Quartile Q4
ENGINEERING, BIOMEDICAL
Rank 95/122
Percentile 22.50
Quartile Q4

JCI (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 253/313
Percentile 19.17
Quartile Q4
DEVELOPMENTAL BIOLOGY
Rank 31/39
Percentile 20.51
Quartile Q4
ENGINEERING, BIOMEDICAL
Rank 86/122
Percentile 29.51
Quartile Q3

Quartile History

Similar Journals

Regenerative Medicine

Advancing the Frontiers of Healing
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

DIFFERENTIATION

Fostering Innovation in Cancer and Cell Biology
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

Journal of Stem Cells & Regenerative Medicine

Innovating Tomorrow's Regenerative Solutions
Publisher: JOURNAL STEM CELLS & REGENERATIVE MEDICINEISSN: 0973-7154Frequency: 2 issues/year

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

International Journal of Stem Cells

Catalyzing Innovations in Stem Cell Applications
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.

STEM CELLS

Exploring breakthroughs in cell and developmental biology.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Elevating Research in Embryology and Beyond
Publisher: UNIV BASQUE COUNTRY UPV-EHU PRESSISSN: 0214-6282Frequency: 12 issues/year

The International Journal of Developmental Biology, published by the University of Basque Country UPV-EHU Press, has been a pivotal resource in the field of developmental biology since its inception in 1989. With an ISSN of 0214-6282 and an E-ISSN of 1696-3547, this journal serves as a platform for groundbreaking research and exploration within the realms of embryology and developmental biology. Although currently classified in the Q4 category for Developmental Biology and Q3 in Embryology as of 2023, the journal continues to provide vital insights that influence contemporary scientific understanding and practices. It ranks 14th out of 21 in the field of Embryology and holds a 35th percentile ranking in this specialized domain, emphasizing its emerging relevance in the academic community. Researchers, professionals, and students alike are encouraged to utilize the journal’s content to enrich their knowledge and drive innovation within developmental sciences. With an eye towards future developments, the journal anticipates continued evolution through the years, maintaining its commitment to high-quality, impactful research.

Cells & Development

Shedding Light on Molecular Interactions in Growth
Publisher: ELSEVIERISSN: 2667-2901Frequency: 4 issues/year

Cells & Development is a premier journal published by Elsevier, dedicated to advancing the field of Developmental Biology. With an ISSN of 2667-2901 and an impressive Q2 ranking in its category for 2023, the journal endeavors to provide a platform for high-quality research articles that explore cellular mechanisms, developmental processes, and molecular interactions that underpin growth and differentiation. Based in the Netherlands, Cells & Development not only emphasizes the importance of innovative experimental approaches but also encourages interdisciplinary contributions that bridge the gap between basic and applied science. As an Open Access publication, it ensures that research findings are readily accessible to a global audience, significantly enhancing visibility and impact. The journal's commitment to scholarly excellence makes it an essential resource for researchers, professionals, and students aiming to contribute to the dynamic field of developmental biology.

FASEB BioAdvances

Exploring Breakthroughs in Biological Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

DEVELOPMENTAL CELL

Charting New Pathways in Biochemistry and Genetics
Publisher: CELL PRESSISSN: 1534-5807Frequency: 12 issues/year

DEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.

npj Regenerative Medicine

Pioneering Research for Tomorrow's Therapies.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.